138 related articles for article (PubMed ID: 12450694)
1. Safety and efficacy of E coli enterotoxin adjuvant for urease-based rectal immunization against Helicobacter pylori.
Sougioultzis S; Lee CK; Alsahli M; Banerjee S; Cadoz M; Schrader R; Guy B; Bedford P; Monath TP; Kelly CP; Michetti P
Vaccine; 2002 Dec; 21(3-4):194-201. PubMed ID: 12450694
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers.
Banerjee S; Medina-Fatimi A; Nichols R; Tendler D; Michetti M; Simon J; Kelly CP; Monath TP; Michetti P
Gut; 2002 Nov; 51(5):634-40. PubMed ID: 12377799
[TBL] [Abstract][Full Text] [Related]
3. Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection.
Weltzin R; Guy B; Thomas WD; Giannasca PJ; Monath TP
Infect Immun; 2000 May; 68(5):2775-82. PubMed ID: 10768972
[TBL] [Abstract][Full Text] [Related]
4. The mucosal adjuvanticity of two nontoxic mutants of Escherichia coli heat-labile enterotoxin varies with immunization routes.
Park EJ; Chang JH; Kim JS; Yum JS; Chung SI
Exp Mol Med; 2000 Jun; 32(2):72-8. PubMed ID: 10926118
[TBL] [Abstract][Full Text] [Related]
5. Vaccination against Helicobacter pylori in non-human primate models and humans.
Lee CK
Scand J Immunol; 2001 May; 53(5):437-42. PubMed ID: 11309150
[TBL] [Abstract][Full Text] [Related]
6. Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection.
Kleanthous H; Myers GA; Georgakopoulos KM; Tibbitts TJ; Ingrassia JW; Gray HL; Ding R; Zhang ZZ; Lei W; Nichols R; Lee CK; Ermak TH; Monath TP
Infect Immun; 1998 Jun; 66(6):2879-86. PubMed ID: 9596763
[TBL] [Abstract][Full Text] [Related]
7. Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys.
Lee CK; Soike K; Hill J; Georgakopoulos K; Tibbitts T; Ingrassia J; Gray H; Boden J; Kleanthous H; Giannasca P; Ermak T; Weltzin R; Blanchard J; Monath TP
Vaccine; 1999 Mar; 17(11-12):1493-505. PubMed ID: 10195786
[TBL] [Abstract][Full Text] [Related]
8. Oral immunization with recombinant Helicobacter pylori urease confers long-lasting immunity against Helicobacter felis infection.
Myers GA; Ermak TH; Georgakopoulos K; Tibbitts T; Ingrassia J; Gray H; Kleanthous H; Lee CK; Monath TP
Vaccine; 1999 Mar; 17(11-12):1394-403. PubMed ID: 10195775
[TBL] [Abstract][Full Text] [Related]
9. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults.
Michetti P; Kreiss C; Kotloff KL; Porta N; Blanco JL; Bachmann D; Herranz M; Saldinger PF; Corthésy-Theulaz I; Losonsky G; Nichols R; Simon J; Stolte M; Ackerman S; Monath TP; Blum AL
Gastroenterology; 1999 Apr; 116(4):804-12. PubMed ID: 10092302
[TBL] [Abstract][Full Text] [Related]
10. Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection.
Weltzin R; Kleanthous H; Guirakhoo F; Monath TP; Lee CK
Vaccine; 1997 Mar; 15(4):370-6. PubMed ID: 9141207
[TBL] [Abstract][Full Text] [Related]
11. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection.
Kotloff KL; Sztein MB; Wasserman SS; Losonsky GA; DiLorenzo SC; Walker RI
Infect Immun; 2001 Jun; 69(6):3581-90. PubMed ID: 11349017
[TBL] [Abstract][Full Text] [Related]
13. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis.
Lee CK; Weltzin R; Thomas WD; Kleanthous H; Ermak TH; Soman G; Hill JE; Ackerman SK; Monath TP
J Infect Dis; 1995 Jul; 172(1):161-72. PubMed ID: 7797906
[TBL] [Abstract][Full Text] [Related]
14. The New World primate, Aotus nancymae, as a model for examining the immunogenicity of a prototype enterotoxigenic Escherichia coli subunit vaccine.
Jones FR; Hall ER; Tribble D; Savarino SJ; Cassels FJ; Porter C; Meza R; Nunez G; Espinoza N; Salazar M; Luckett R; Scott D
Vaccine; 2006 May; 24(18):3786-92. PubMed ID: 16343702
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and safety of recombinant Helicobacter pylori urease in a nonhuman primate.
Stadtländer CT; Gangemi JD; Khanolkar SS; Kitsos CM; Farris HE; Fulton LK; Hill JE; Huntington FK; Lee CK; Monath TP
Dig Dis Sci; 1996 Sep; 41(9):1853-62. PubMed ID: 8794806
[TBL] [Abstract][Full Text] [Related]
16. Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study.
McKenzie R; Bourgeois AL; Frech SA; Flyer DC; Bloom A; Kazempour K; Glenn GM
Vaccine; 2007 May; 25(18):3684-91. PubMed ID: 17313998
[TBL] [Abstract][Full Text] [Related]
17. Immunological response of recombinant H. pylori multi-epitope vaccine with different vaccination strategies.
Wang B; Pan X; Wang H; Zhou Y; Zhu J; Yang J; Li W
Int J Clin Exp Pathol; 2014; 7(10):6559-66. PubMed ID: 25400734
[TBL] [Abstract][Full Text] [Related]
18. [Immunopotency of the recombinant urease B subunit vaccine of Helicobacter pylori after intranasal administration to mice].
Gao ZG; Zou QM; Guo G; Guo TS; Zou QM; Zeng WK; Xie QH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):68-70. PubMed ID: 15132912
[TBL] [Abstract][Full Text] [Related]
19. A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization.
Bernstein DI; Pasetti MF; Brady R; Buskirk AD; Wahid R; Dickey M; Cohen M; Baughman H; El-Khorazaty J; Maier N; Sztein MB; Baqar S; Bourgeois AL
Vaccine; 2019 Jan; 37(4):602-611. PubMed ID: 30563789
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori.
Xing Y; Liu W; Li X; Guo L; Lv X; Xi T
Biochem Biophys Res Commun; 2015 Jul; 462(3):269-74. PubMed ID: 25957472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]